PerformanceAlthough the WELL takeover of CRH has got tongues wagging, IMHO, it's way too soon for speculation on a buyout and/or comparisons with large US firms. But if DOC can produce the financial results, then good things will happen.
As an example, look at Acuity Ads. They are in a sector that has started to boom during the pandemic (as is the case with DOC). But they also developed a new product that is doing very well. So when people then began to look at the results and potential, comparisons with larger US peers were taken seriously and AT was considered very cheap in comparison. Last summer, AT was a buck and is now pushing $30. If DOC can follow through with its performance, then we can start doing realistic comparisons and the SP could really start to move. GLTA